AngioDynamics
ANGO
157 hedge funds and large institutions have $593M invested in AngioDynamics in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 34 closing their positions.
2,809% more call options, than puts
Call options by funds: $320K | Put options by funds: $11K
15% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 55
1.76% less ownership
Funds ownership: 100.33% → 98.57% (-1.8%)
9% less funds holding
Funds holding: 173 → 157 (-16)
14% less capital invested
Capital invested by funds: $692M → $593M (-$98.3M)
41% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$8.46M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$6.97M |
| 3 |
BlackRock
New York
|
+$6.88M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$4.25M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$28.7M |
| 2 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$12.6M |
| 3 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$10.5M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$7.67M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$4.24M |
ANGO Hedge Fund Activity: Q4 2019 in Review
157 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2019, worth a combined $593M — down 14% from $692M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of ANGO and 20 opened new positions — a net loss of 14 holders — while 55 trimmed existing stakes and 63 added.
The largest buyer was Victory Capital Management, adding an estimated $8.46M. The largest seller was Lazard Asset Management, exiting entirely with an estimated $28.7M sold.
- 157 institutional investors held AngioDynamics (ANGO) as of Q4 2019, down from 173 in Q3 2019.
- Funds reported $593M of AngioDynamics stock for Q4 2019, down 14% quarter-over-quarter.
- 20 funds opened new AngioDynamics positions in Q4 2019 and 34 closed out, a net change of -14 holders.
- The largest AngioDynamics buyer in Q4 2019 was Victory Capital Management, an estimated $8.46M added.
- The largest AngioDynamics seller in Q4 2019 was Lazard Asset Management, an estimated $28.7M sold.
Based on aggregated 13F filings for Q4 2019.